NORMMED is pleased to announce its participation as a Gold Sponsor of the Global Spine Congress (GSC) 2026, the leading world-class spine congress that brings together thousands of spine surgeons and spine care professionals from across the globe. Taking place in May 2026 in Istanbul, Türkiye, the Global Spine Congress will welcome spine specialists worldwide to engage in a … [Read more...] about NORMMED Gold Sponsor of the Global Spine Congress (GSC)2026
NEWS
We are proud to announce that Dymicron will be a Sponsor of SPINEMarketGroup in 2026!
Thank you, Dymicron! On behalf of the SPINEMarketGroup team, we sincerely appreciate your support as a PLATINUM Sponsor for 2026. We are proud to welcome Dymicron as a sponsor for the first time and look forward to starting this journey together. About Dymicron Dymicron is a privately held medical technology company with a new generation of musculoskeletal … [Read more...] about We are proud to announce that Dymicron will be a Sponsor of SPINEMarketGroup in 2026!
FDA grants 510k approval for Lincotek’s Medical Division new Cervical Implant System
Lincotek’s SpineLinc to reduce time to market for orthopedic manufacturers. Parma, Italy | January 13, 2026: The Medical Division of Lincotek – global solution provider for services in the medical devices industry – has announced that the U.S. Food and Drug Administration (FDA) has granted 510k clearance for the company’s SpineLinc Anterior Cervical Implant … [Read more...] about FDA grants 510k approval for Lincotek’s Medical Division new Cervical Implant System
We are proud to announce that Genesys Spine will once again be a Sponsor of SPINEMarketGroup in 2026!
Thank you, Genesys Spine! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About Genesys Spine Founded in December of 2009, Genesys Spine’s mission was to bring a suite of medical implants and instruments with novel characteristics … [Read more...] about We are proud to announce that Genesys Spine will once again be a Sponsor of SPINEMarketGroup in 2026!
Proprio’s Fourth FDA Clearance Highlights Growing Shift to 3D Measurement in Spine Care
SEATTLE, Jan. 15, 2026 /PRNewswire/ -- Proprio, the surgical technology company pioneering real-time, AI-powered intraoperative guidance and data-driven surgical workflows, today announced the U.S. Food and Drug Administration (FDA) has granted clearance for the "Picasso" feature. This marks the company's fourth FDA-cleared capability within its Paradigm platform. The … [Read more...] about Proprio’s Fourth FDA Clearance Highlights Growing Shift to 3D Measurement in Spine Care
Dymicron Announces First Patient Enrolled in Triadyme-C IDE Clinical Trial
OREM, Utah, Jan. 15, 2026 /PRNewswire/ -- Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced the successful enrollment and treatment of the first patient in its Triadyme®-C Investigational Device Exemption (IDE) clinical trial. This milestone marks the initiation of a U.S. clinical study evaluating the safety … [Read more...] about Dymicron Announces First Patient Enrolled in Triadyme-C IDE Clinical Trial
VB Spine to Acquire Intraoperative Visualization Platform From Robotron Surgical Technologies
New York, NY and Miami, FL, January 15, 2026 – VB Spine LLC (“VB Spine”) today announced an agreement to acquire the SpineHawk™ platform from Robotron Surgical Technologies, expanding VB Spine’s portfolio with intraoperative spinal visualization and a software roadmap intended to support technology-enabled spine care. Robotron Surgical Technologies, a developer of advanced … [Read more...] about VB Spine to Acquire Intraoperative Visualization Platform From Robotron Surgical Technologies
We are proud to announce that SpineGuard will once again be a Sponsor of SPINEMarketGroup in 2026!
Thank you, SpineGuard! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About SpineGuard Pierre Jérôme and Stéphane Bette founded SpineGuard in January 2009 with the goal of delivering the clinical benefits of the DSG™ (Dynamic … [Read more...] about We are proud to announce that SpineGuard will once again be a Sponsor of SPINEMarketGroup in 2026!
MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™
EDISON, N.J. & SALT LAKE CITY--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of orthobiologic solutions, today announced the launch of Summit Matrix™, an advanced synthetic bone graft designed to improve bone … [Read more...] about MTF Biologics and Kolosis BIO Launch New Solution for Orthopedic and Spinal Surgeries: Summit Matrix™
SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In the final quarter of 2025, Spineway, a specialist in innovative implants for the treatment of severe spine disorders, benefited from an acceleration in sales across all of its markets and the receipt of key account orders deferred from the first half of the year. With revenue of … [Read more...] about SPINEWAY : 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%)
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
CARLSBAD, Calif. and FREDERICK, Md., Jan. 12, 2026 /PRNewswire/ -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing spine surgery, and Theradaptive, Inc., a clinical-stage regenerative medicine company pioneering engineered protein therapeutics, today announced a definitive strategic partnership agreement. Concurrently, … [Read more...] about ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
We are proud to announce that normmed will once again be a Sponsor of SPINEMarketGroup in 2026!
Thank you, normmed! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About normmed normmed makes a difference in both domestic and international markets with innovative solutions in its field and progresses on this path. normmed, … [Read more...] about We are proud to announce that normmed will once again be a Sponsor of SPINEMarketGroup in 2026!
Spineology Launches OptiMesh® HA Nano
St. Paul, MN – January 13, 2026 – Spineology Inc., the pioneer in conforming patient-specific expandable implant technology, today announced the launch of OptiMesh HA Nano, the company’s latest advancement in personalized spinal care. The launch represents a significant step forward in expandable interbody fusion innovation, combining Spineology’s proprietary … [Read more...] about Spineology Launches OptiMesh® HA Nano
Vy Spine Announces FDA Clearance for VyBrate VBR System
Bountiful, UT – January 13, 2025—Vy Spine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its VyBrate VBR System which is designed for use in both the cervical and thoracolumbar spine for vertebral body replacement surgery. The VyBrate VBR is an … [Read more...] about Vy Spine Announces FDA Clearance for VyBrate VBR System
We are proud to announce that GLOBAL biomedica will once again be a Sponsor of SPINEMarketGroup in 2026!
Thank you, GLOBAL biomedica! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2026.We are very proud to continue this journey together for another year! About GLOBAL biomedica GLOBAL biomedica is manufacturer of orthopedic titanium implants, extended by designing and constructing in collaboration with leading … [Read more...] about We are proud to announce that GLOBAL biomedica will once again be a Sponsor of SPINEMarketGroup in 2026!
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
WARSAW, Ind., Jan. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited financial highlights for the fourth quarter and full year ended December 31, 2025, issued 2026 financial guidance, and provided business … [Read more...] about OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2025 and Issues 2026 Financial Guidance
Seven Leading Augmented (AR) and Extended Reality (XR) Systems in Spine Surgery
In the 1990s, the first spine navigation systems were introduced. They represented a true revolution, assisting surgeons during screw placement by providing more information and therefore greater safety. Many years passed before robotic systems and other advanced technologies appeared, and only quite recently did this market begin to develop significantly. However, … [Read more...] about Seven Leading Augmented (AR) and Extended Reality (XR) Systems in Spine Surgery
ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today preliminary financial results for the fourth quarter and full-year ended December 31, 2025. The Company also provided a financial outlook for full-year 2026. Preliminary, … [Read more...] about ATEC Announces Select Preliminary Financial Results for 2025 and Provides 2026 Outlook
Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today … [Read more...] about Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025